Evaluation of High Dosages of Oral Meloxicam in American Kestrels (Falco sparverius)

Noémie M. Summa, David Guzman, Sylvain Larrat, Eric Troncy, David M. Bird, Stéphane Lair, Guy Fitzgerald

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

To evaluate the toxicity of short-term high doses of meloxicam in American kestrels (Falco sparverius), 32 male captive-born, 1- to 4-year-old American kestrels were randomly assigned to 4 groups: 3 groups treated with meloxicam (n = 9 per group) and a control group (n = 5). Meloxicam was administered orally via feeding tube in the proventriculus at 2, 10, and 20 mg/kg every 12 hours for 7 days for the treatment groups, while the control group received saline solution. The birds were evaluated for the presence of clinical signs, abnormalities in the complete blood cell count and in the plasma biochemical panel for the 20-mg/kg group, and gross and histopathologic lesions. No clinical signs or mortality were observed in any group. No significant differences of clinical relevance were found in results of the packed cell volume, total solids, and biochemical panel, and no evidence of renal toxicity was found in the treatment or control groups. A significant correlation was found between hepatic lipidosis and meloxicam dose (P = .02). Two of 9 birds in the 20-mg/kg group developed gastric ulcers, although this result was not significant. None of the birds in the 2- and 10-mg/kg groups had similar lesions. Finally, meloxicam dosages up to 20 mg/kg did not result in nephrotoxicity in American kestrels. Further toxicologic studies to evaluate hepatotoxicity and gastrotoxicity of meloxicam in avian species are needed.

Original languageEnglish (US)
Pages (from-to)108-116
Number of pages9
JournalJournal of Avian Medicine and Surgery
Volume31
Issue number2
DOIs
StatePublished - Jun 1 2017

Fingerprint

meloxicam
Falco sparverius
mouth
dosage
Birds
nephrotoxicity
Blood Cell Count
lesions (animal)
Control Groups
birds
Proventriculus
Lipidoses
blood cell counts
stomach ulcers
proventriculus
tube feeding
hepatotoxicity
Enteral Nutrition
acute toxicity
Stomach Ulcer

Keywords

  • American kestrel
  • avian
  • Falco sparverius
  • meloxicam
  • NSAID
  • toxicity

ASJC Scopus subject areas

  • Small Animals

Cite this

Evaluation of High Dosages of Oral Meloxicam in American Kestrels (Falco sparverius). / Summa, Noémie M.; Guzman, David; Larrat, Sylvain; Troncy, Eric; Bird, David M.; Lair, Stéphane; Fitzgerald, Guy.

In: Journal of Avian Medicine and Surgery, Vol. 31, No. 2, 01.06.2017, p. 108-116.

Research output: Contribution to journalArticle

Summa, Noémie M. ; Guzman, David ; Larrat, Sylvain ; Troncy, Eric ; Bird, David M. ; Lair, Stéphane ; Fitzgerald, Guy. / Evaluation of High Dosages of Oral Meloxicam in American Kestrels (Falco sparverius). In: Journal of Avian Medicine and Surgery. 2017 ; Vol. 31, No. 2. pp. 108-116.
@article{893fd4dd1d744ddfbe8a468a9d8480f2,
title = "Evaluation of High Dosages of Oral Meloxicam in American Kestrels (Falco sparverius)",
abstract = "To evaluate the toxicity of short-term high doses of meloxicam in American kestrels (Falco sparverius), 32 male captive-born, 1- to 4-year-old American kestrels were randomly assigned to 4 groups: 3 groups treated with meloxicam (n = 9 per group) and a control group (n = 5). Meloxicam was administered orally via feeding tube in the proventriculus at 2, 10, and 20 mg/kg every 12 hours for 7 days for the treatment groups, while the control group received saline solution. The birds were evaluated for the presence of clinical signs, abnormalities in the complete blood cell count and in the plasma biochemical panel for the 20-mg/kg group, and gross and histopathologic lesions. No clinical signs or mortality were observed in any group. No significant differences of clinical relevance were found in results of the packed cell volume, total solids, and biochemical panel, and no evidence of renal toxicity was found in the treatment or control groups. A significant correlation was found between hepatic lipidosis and meloxicam dose (P = .02). Two of 9 birds in the 20-mg/kg group developed gastric ulcers, although this result was not significant. None of the birds in the 2- and 10-mg/kg groups had similar lesions. Finally, meloxicam dosages up to 20 mg/kg did not result in nephrotoxicity in American kestrels. Further toxicologic studies to evaluate hepatotoxicity and gastrotoxicity of meloxicam in avian species are needed.",
keywords = "American kestrel, avian, Falco sparverius, meloxicam, NSAID, toxicity",
author = "Summa, {No{\'e}mie M.} and David Guzman and Sylvain Larrat and Eric Troncy and Bird, {David M.} and St{\'e}phane Lair and Guy Fitzgerald",
year = "2017",
month = "6",
day = "1",
doi = "10.1647/2015-150",
language = "English (US)",
volume = "31",
pages = "108--116",
journal = "Journal of Avian Medicine and Surgery",
issn = "1082-6742",
publisher = "Association of Avian Veterinarians",
number = "2",

}

TY - JOUR

T1 - Evaluation of High Dosages of Oral Meloxicam in American Kestrels (Falco sparverius)

AU - Summa, Noémie M.

AU - Guzman, David

AU - Larrat, Sylvain

AU - Troncy, Eric

AU - Bird, David M.

AU - Lair, Stéphane

AU - Fitzgerald, Guy

PY - 2017/6/1

Y1 - 2017/6/1

N2 - To evaluate the toxicity of short-term high doses of meloxicam in American kestrels (Falco sparverius), 32 male captive-born, 1- to 4-year-old American kestrels were randomly assigned to 4 groups: 3 groups treated with meloxicam (n = 9 per group) and a control group (n = 5). Meloxicam was administered orally via feeding tube in the proventriculus at 2, 10, and 20 mg/kg every 12 hours for 7 days for the treatment groups, while the control group received saline solution. The birds were evaluated for the presence of clinical signs, abnormalities in the complete blood cell count and in the plasma biochemical panel for the 20-mg/kg group, and gross and histopathologic lesions. No clinical signs or mortality were observed in any group. No significant differences of clinical relevance were found in results of the packed cell volume, total solids, and biochemical panel, and no evidence of renal toxicity was found in the treatment or control groups. A significant correlation was found between hepatic lipidosis and meloxicam dose (P = .02). Two of 9 birds in the 20-mg/kg group developed gastric ulcers, although this result was not significant. None of the birds in the 2- and 10-mg/kg groups had similar lesions. Finally, meloxicam dosages up to 20 mg/kg did not result in nephrotoxicity in American kestrels. Further toxicologic studies to evaluate hepatotoxicity and gastrotoxicity of meloxicam in avian species are needed.

AB - To evaluate the toxicity of short-term high doses of meloxicam in American kestrels (Falco sparverius), 32 male captive-born, 1- to 4-year-old American kestrels were randomly assigned to 4 groups: 3 groups treated with meloxicam (n = 9 per group) and a control group (n = 5). Meloxicam was administered orally via feeding tube in the proventriculus at 2, 10, and 20 mg/kg every 12 hours for 7 days for the treatment groups, while the control group received saline solution. The birds were evaluated for the presence of clinical signs, abnormalities in the complete blood cell count and in the plasma biochemical panel for the 20-mg/kg group, and gross and histopathologic lesions. No clinical signs or mortality were observed in any group. No significant differences of clinical relevance were found in results of the packed cell volume, total solids, and biochemical panel, and no evidence of renal toxicity was found in the treatment or control groups. A significant correlation was found between hepatic lipidosis and meloxicam dose (P = .02). Two of 9 birds in the 20-mg/kg group developed gastric ulcers, although this result was not significant. None of the birds in the 2- and 10-mg/kg groups had similar lesions. Finally, meloxicam dosages up to 20 mg/kg did not result in nephrotoxicity in American kestrels. Further toxicologic studies to evaluate hepatotoxicity and gastrotoxicity of meloxicam in avian species are needed.

KW - American kestrel

KW - avian

KW - Falco sparverius

KW - meloxicam

KW - NSAID

KW - toxicity

UR - http://www.scopus.com/inward/record.url?scp=85021686581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021686581&partnerID=8YFLogxK

U2 - 10.1647/2015-150

DO - 10.1647/2015-150

M3 - Article

C2 - 28644089

AN - SCOPUS:85021686581

VL - 31

SP - 108

EP - 116

JO - Journal of Avian Medicine and Surgery

JF - Journal of Avian Medicine and Surgery

SN - 1082-6742

IS - 2

ER -